As part of the continuing efforts to reduce the risks associated with the anti-seizure medication (ASM), Topirimate (Topamax), the Health Products Regulatory Authority (HPRA) have recently reissued patient information materials and reminders to prescribers and pharmacists about their obligations under the Pregnancy Prevention Programme (PPP) and risk reduction measures associated with the medication.
Researchers at Trinity College Dublin are inviting adults with epilepsy in Ireland to take part in a study exploring the link between interoception (how we sense internal body signals, like our heartbeat) and emotional regulation.
Epilepsy Ireland’s Annual General Meeting (AGM) takes place this evening (Monday 8th Sept) at 6pm via Zoom.
Due to a technical issue, the original link circulated to all members three weeks ago has expired and no longer works. Members have been issued with a new link for the meeting this morning by email.
If you are a member of Epilepsy Ireland and you were planning to attend the AGM, please check your email for the updated link.
With our Research Funding call recently launched, it is fantastic to see a previously funded project featured in Epilepsia!
Look back on how we continued our journey towards a society where no person's life is limited by epilepsy in 2024.
Whether parents, children and schools alike can believe it or not - it is back to school season! At Epilepsy Ireland, we regularly support parents supporting children with the condition with the return to school, as well as schools themselves who may be seeking to learn more about a condition which affects over 10,000 children in Ireland.
A researcher from Trinity College Dublin is conducting a study examining how parents who care for a child with a chronic condition (such as epilepsy) manage the overlapping responsibilities of being a caregiver with other life roles, and how this affects their well-being.
The inquiry into Sodium Valproate has begun - find out how you can engage with the inquiry's work.
Researchers and research institutions - we have issued our 9th Research Funding Call!
As part of the continuing efforts to reduce the risks associated with the anti-seizure medication, Sodium Valproate (Epilim), the Health Products Regulatory Authority (HPRA) have recently reissued patient information materials and reminders to prescribers and pharmacists about their obligations under the Pregnancy Prevention Programme (PPP) and risk reduction measures associated with the medication.